Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes

被引:101
作者
Baqui, M
Botero, D
Gereben, B
Curcio, C
Harney, JW
Salvatore, D
Sorimachi, K
Larsen, PR
Bianco, AC
机构
[1] Brigham & Womens Hosp, Dept Med, Thyroid Sect, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
D O I
10.1074/jbc.M210266200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The type 3 iodothyronine selenodeiodinase (D3) is an integral membrane protein that inactivates thyroid hormones. By using immunofluorescence cytochemistry confocal microscopy of live or fixed cells transiently expressing FLAG-tagged human D3 or monkey hepatocarcinoma cells expressing endogenous D3, we identified D3 in the plasma membrane. It co-localizes with Na,K-ATPase alpha, with the early endosomal marker EEA-1 and clathrin, but not with two endoplasmic reticulum resident proteins. Most of the D3 molecule is extracellular and can be biotinylated with a cell-impermeant probe. There is constant internalization of D3 that is blocked by sucrose or methyl-beta-cyclodextrin-containing medium. Exposing cells to a weak base such as primaquine increases the pool of internalized D3, suggesting that D3 is recycled between plasma membrane and early endosomes. Such recycling could account for the much longer half-life of D3 (12 h) than the thyroxine activating members of the selenodeiodinase family, type I (D1; 8 h) or type 2 (D2; 2 h) deiodinase. The extracellular location of D3 gives ready access to circulating thyroid hormones, explaining its capacity for rapid inactivation of circulating thyroxine and triiodothyronine in patients with hemangiomas and its blockade of the access of maternal thyroid hormones to the human fetus.
引用
收藏
页码:1206 / 1211
页数:6
相关论文
共 31 条
  • [11] HYPERTONIC MEDIA INHIBIT RECEPTOR-MEDIATED ENDOCYTOSIS BY BLOCKING CLATHRIN-COATED PIT FORMATION
    HEUSER, JE
    ANDERSON, RGW
    [J]. JOURNAL OF CELL BIOLOGY, 1989, 108 (02) : 389 - 400
  • [12] HUANG H, 2003, IN PRESS J CLIN ENDO
  • [13] Metamorphosis is inhibited in transgenic Xenopus laevis tadpoles that overexpress type III deiodinase
    Huang, HC
    Marsh-Armstrong, N
    Brown, DD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) : 962 - 967
  • [14] Brief report: Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.
    Huang, SA
    Tu, HM
    Harney, JW
    Venihaki, M
    Butte, AJ
    Kozakewich, HPW
    Fishman, SJ
    Larsen, PR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (03) : 185 - 189
  • [15] A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase
    Huang, SA
    Fish, SA
    Dorfman, DM
    Salvatore, D
    Kozakewich, HPW
    Mandel, SJ
    Larsen, PR
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) : 4457 - 4461
  • [16] BASOLATERAL SORTING IN MDCK CELLS REQUIRES A DISTINCT CYTOPLASMIC DOMAIN DETERMINANT
    HUNZIKER, W
    HARTER, C
    MATTER, K
    MELLMAN, I
    [J]. CELL, 1991, 66 (05) : 907 - 920
  • [17] ALTERATION OF THE MYOMETRIAL PLASMA-MEMBRANE CHOLESTEROL CONTENT WITH BETA-CYCLODEXTRIN MODULATES THE BINDING-AFFINITY OF THE OXYTOCIN RECEPTOR
    KLEIN, U
    GIMPL, G
    FAHRENHOLZ, F
    [J]. BIOCHEMISTRY, 1995, 34 (42) : 13784 - 13793
  • [18] Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase
    Marsh-Armstrong, N
    Huang, HC
    Remo, BF
    Liu, TT
    Brown, DD
    [J]. NEURON, 1999, 24 (04) : 871 - 878
  • [19] DIFFERENTIAL-EFFECTS OF ALPHA-CYCLODEXTRINS, BETA-CYCLODEXTRINS AND GAMMA-CYCLODEXTRINS ON HUMAN-ERYTHROCYTES
    OHTANI, Y
    IRIE, T
    UEKAMA, K
    FUKUNAGA, K
    PITHA, J
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 186 (1-2): : 17 - 22
  • [20] Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase
    Park, H
    Go, YM
    John, PLS
    Maland, MC
    Lisanti, MP
    Abrahamson, DR
    Jo, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) : 32304 - 32311